Firefly Neuroscience Appoints Greg Lipschitz as Executive Chairman, Strengthening AI-Driven Brain Health Solutions

Firefly Neuroscience Announces Leadership Change

Firefly Neuroscience, Inc. (NASDAQ: AIFF), an artificial intelligence company specializing in brain health solutions, has appointed Greg Lipschitz as its new Executive Chairman, effective December 3, 2024 1

1

2

2

. This strategic move comes as the company prepares to commercialize its innovative technology in the coming year.

Greg Lipschitz's Background and New Role

Mr. Lipschitz, who has served on Firefly's board since December 2022, brings over 13 years of experience in private equity, merchant banking, capital markets, and finance to his new role 1

1

. His appointment is seen as a crucial step in advancing the company's agenda, particularly given his extensive capital markets knowledge.

In his statement, Lipschitz expressed enthusiasm for his expanded role: "I believe that Firefly is uniquely positioned at the intersection of artificial intelligence and brain health that I have long been passionate about, and I look forward to continuing my journey with the Company in this next chapter" 1

1

2

2

.

Firefly's AI-Driven Brain Health Technology

Firefly's core offering is its FDA-510(k) cleared Brain Network Analytics (BNA™) technology, which aims to revolutionize diagnostic and treatment monitoring methods for various neurological and mental disorders 1

1

2

2

. The technology was developed using AI and machine learning, leveraging a proprietary database of over 17,000 patient EEGs representing twelve disorders.

Commercialization Plans and Market Focus

The company is now launching BNA™ commercially, targeting two primary markets:

1. Pharmaceutical companies engaged in drug research and clinical trials
2. Medical practitioners for clinical use 1

   1

   2

   2

This commercialization effort marks a significant milestone for Firefly, as it transitions from research and development to market application of its AI-driven brain health solutions.

Leadership Transition

As part of this leadership change, Mr. David Johnson has resigned from the board and stepped down as Executive Chairman, effective November 30, 2024 1

1

2

2

. The company stated that this transition was not due to any disagreements and thanked Mr. Johnson for his contributions.

Future Outlook and Challenges

While Firefly's board expresses confidence in this leadership transition and the company's future, they also acknowledge potential risks and uncertainties 1

1

2

2

. These include challenges related to the development and commercialization of BNA technology and the company's ability to realize the anticipated benefits of its recent merger with WaveDancer, Inc.

As Firefly Neuroscience enters this new phase under Lipschitz's leadership, the company aims to leverage its AI-driven technology to improve brain health outcomes for patients with neurological and mental disorders, potentially reshaping the landscape of brain health diagnostics and treatment.